the retail equity raising, page-16

The underwriter won't be sweating- they'd get fees and charges to well match any loss of share price. They'll sleep well at night. They may even have upside from their investment now, later down the track.

You'd have to say raising $317m for a purchase,and adding debt, is a "company maker" for MRM. Can it integrate the new purchase well, or will there be teething problems that become structural problems or cultural fit issues?

Worthwhile reading the recommendations on MRM:

http://www.fnarena.com/dsp_recommendations.cfm?searchsymbol=mrm

Shaw Stockbroking has a $4.10 price target on MRM as it likes the new purchase (link for AFR members or take an AFR free trial):

http://www.afr.com/Page/Uuid/1b31344a-9e7f-11e3-a811-c14997518fac